BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28124231)

  • 1. Left atrial size and function as assessed by computed tomography in cardiac resynchronization therapy: Association to echocardiographic and clinical outcome.
    Hansen PB; Sommer A; Nørgaard BL; Kronborg MB; Nielsen JC
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):917-925. PubMed ID: 28124231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left atrial function, a new predictor of response to cardiac resynchronization therapy?
    Feneon D; Behaghel A; Bernard A; Fournet M; Mabo P; Daubert JC; Leclercq C; Donal E
    Heart Rhythm; 2015 Aug; 12(8):1800-6. PubMed ID: 25896013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of New-Onset Atrial Fibrillation in Patients Receiving CRT: Mechanistic Insights From Speckle Tracking Imaging.
    Sade LE; Atar I; Özin B; Yüce D; Müderrisoğlu H
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):99-111. PubMed ID: 26684972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indexed maximal left atrial volume predicts response to cardiac resynchronization therapy.
    Rossi L; Malagoli A; Piepoli M; Franchi F; Malavasi V; Casali E; Rusticali G; Villani GQ
    Int J Cardiol; 2013 Oct; 168(4):3629-33. PubMed ID: 23725913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapy.
    Buss SJ; Humpert PM; Bekeredjian R; Hardt SE; Zugck C; Schellberg D; Bauer A; Filusch A; Kuecherer H; Katus HA; Korosoglou G
    JACC Cardiovasc Imaging; 2009 May; 2(5):535-43. PubMed ID: 19442937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model-based navigation of left and right ventricular leads to optimal targets for cardiac resynchronization therapy: a single-center feasibility study.
    Laksman Z; Yee R; Stirrat J; Gula LJ; Skanes AC; Leong-Sit P; Manlucu J; McCarty D; Turkistani Y; Scholl D; Rajchl M; Goela A; Islam A; Thompson RT; Drangova M; White JA
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1040-7. PubMed ID: 25221334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Detrimental Effect of RA Pacing on LA Function and Clinical Outcome in Cardiac Resynchronization Therapy.
    Martens P; Deferm S; Bertrand PB; Verbrugge FH; Ramaekers J; Verhaert D; Dupont M; Vandervoort PM; Mullens W
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):895-906. PubMed ID: 31326478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cardiac resynchronization therapy on left atrial reverse remodeling: role of echocardiographic AV delay optimization.
    Malagoli A; Rossi L; Franchi F; Piepoli MF; Malavasi V; Casali E; Modena MG; Villani GQ
    Int J Cardiol; 2013 Aug; 167(4):1456-60. PubMed ID: 22560916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Cardiac Resynchronization Therapy on Left Atrial Size and Function as Expressed by Speckle Tracking 2-Dimensional Strain.
    Valzania C; Gadler F; Boriani G; Rapezzi C; Eriksson MJ
    Am J Cardiol; 2016 Jul; 118(2):237-43. PubMed ID: 27241837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time three-dimensional echocardiography as a novel approach to assess left ventricular and left atrium reverse remodeling and to predict response to cardiac resynchronization therapy.
    Marsan NA; Bleeker GB; Ypenburg C; Van Bommel RJ; Ghio S; Van de Veire NR; Delgado V; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
    Heart Rhythm; 2008 Sep; 5(9):1257-64. PubMed ID: 18774099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of left atrial function is associated with lower incidence of atrial fibrillation and mortality after cardiac resynchronization therapy.
    Fung JW; Yip GW; Zhang Q; Fang F; Chan JY; Li CM; Wu LW; Chan GC; Chan HC; Yu CM
    Heart Rhythm; 2008 Jun; 5(6):780-6. PubMed ID: 18467188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left atrial reverse remodeling and cardiac resynchronization therapy for chronic heart failure patients in sinus rhythm.
    Donal E; Tan K; Leclercq C; Ollivier R; Derumeaux G; Bernard M; de Place C; Mabo P; Daubert JC
    J Am Soc Echocardiogr; 2009 Oct; 22(10):1152-8. PubMed ID: 19665865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial function, atrial volume and cardiovascular clinical outcomes in patients with end-stage renal disease - A study of cardiac computed tomography.
    Dupont L; Winther S; Jørgensen HS; Bomholt P; Bøtker HE; Bøttcher M; Ivarsen P; Svensson M
    J Cardiovasc Comput Tomogr; 2017; 11(5):389-396. PubMed ID: 28705554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events.
    Park JH; Negishi K; Grimm RA; Popovic Z; Stanton T; Wilkoff BL; Marwick TH
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):864-72. PubMed ID: 24084489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of atrial function and atrial reverse remodeling after cardiac resynchronization therapy for heart failure.
    Yu CM; Fang F; Zhang Q; Yip GW; Li CM; Chan JY; Wu L; Fung JW
    J Am Coll Cardiol; 2007 Aug; 50(8):778-85. PubMed ID: 17707183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are changes in the extent of left ventricular dyssynchrony as assessed by speckle tracking associated with response to cardiac resynchronization therapy?
    Ghani A; Delnoy PP; Ottervanger JP; Ramdat Misier AR; Smit JJ; Adiyaman A; Elvan A
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):553-61. PubMed ID: 26585749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT.
    Knappe D; Pouleur AC; Shah AM; Bourgoun M; Brown MW; Foster E; Pfeffer MA; Moss AJ; Solomon SD;
    J Card Fail; 2013 Mar; 19(3):149-55. PubMed ID: 23482074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Piccolo R; Galasso G; Reiter RJ
    Int J Cardiol; 2016 Oct; 221():359-63. PubMed ID: 27404706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.